Clinical evidence shows: daily CoQ10 supplementation reduces mortality risk and hospitalization risk in chronic heart failure patients, enhances antioxidant activity and anti-inflammation activity, promotes better endothelial function and modestly reduces systolic blood pressure.
In heart failure patients, Coenzyme Q10 supplementation reduces all-cause mortality risk, hospitalization for heart failure, and biomarker levels for heart failure. CoQ10 improves left ventricular ejection fraction and 6-minute walk test results. With no major adverse effects.
What is the rationale for the use of Coenzyme Q10 (CoQ10) in the treatment of cardiovascular diseases? Worldwide, cardiovascular diseases are the number one cause [...]
Telomere length is an indicator of the extent to which we are aging biologically. Telomere shortening occurs naturally as we get older. Shortened telomeres are [...]
Heart function suffers considerably in patients with heart failure. The syndrome heart failure is associated with a loss of functional capacity and a diminution of [...]
Statin medications lower both cholesterol and Coenzyme Q10 levels in plasma and muscle tissue. Low CoQ10 levels increase the risk of mitochondrial dysfunction. CoQ10 supplementation helps mitochondrial function and does not affect the efficacy of statin medications.
In heart failure patients, adjuvant treatment with Coenzyme Q10 adds something positive to the standard medicinal treatment. CoQ10 (3 x 100 mg daily) boosts mitochondrial ATP energy generation. Improved ATP energy generation improves the contractility of the heart muscle tissue.
KiSel-10 Study data show sex differences in the responses to the combined CoQ10 and selenium supplementation. The 10-year cardiovascular survival rate was significantly higher in females than in males. Moreover, the improved survival rate kicked in later in females than in males.
Good heart health depends in part on adequate intakes of Coenzyme Q10 and selenium. Combining CoQ10 supplements with selenium supplements gives a theoretical advantage when [...]
Atherosclerosis is the leading cause of cardiovascular disease in the world [Liao 2024]. The condition is characterized by deposits of lipid-containing plaques on the inner [...]
